Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB)

Clinical trial NCT00996333 · COMPLETED

Trial details

NCT number: NCT00996333
Sponsor: Columbia University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Cancer

Start date: 2003-06-01
Primary completion: 2014-10-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.